Human iPSC platform for ASO efficacy and CNS safety screening
iPSC α-Synuclein, Tau & TDP-43 Aggregation Models for Drug Discovery
High-Throughput Screening of Tau, α-Synuclein & TDP-43 Aggregation
Building manufacturing processes for reproducible, multi-yeariPSC-based drug screening
3D iPSC-Derived Cardiac Microtissues for High-Throughput Screening
Scalable iPSC Platform for RNA Therapeutic Efficacy and Toxicity
Subscribe to our newsletter
Stay up to date on iPSC innovations, events and news.
